Quantifying monocyte infiltration in response to intradermal tetanus toxoid injection

Author:

Peng Joanna Z1,Gutstein David E2,Beck Lisa3,Hickey Lisa1,Hustad Carolyn M1,Abbi Smita4,Nirula Ajay5,DeMartino Julie6,Rothenberg Paul7,Gottesdiener Keith8,Bloomfield Daniel M1,Wagner John A1

Affiliation:

1. Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA

2. Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.

3. Johns Hopkins University School of Medicine, Baltimore, MD, USA

4. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

5. Biogen Idec, San Diego, CA, USA

6. Hoffman-LaRoche, Inc., Nutley, NJ, USA

7. J & J Pharmaceutical Research & Development, LLC, Raritan, NJ, USA

8. Rhythm Pharmaceuticals, Boston, MA, USA

Abstract

Aims: To characterize monocyte response in a delayed-type hypersensitivity reaction to intradermal tetanus toxoid (TT) injection. Materials & methods: Men with positive serum anti-tetanus titers were stratified by last TT vaccination. Subjects were administered three intradermal injections of TT and one saline control on the same side of the back. Skin biopsies were taken post-injection. After 2 weeks, the procedure was repeated on the contralateral side. Results: Men who received TT booster vaccination 1 month before the study showed greater reproducibility and lower variability in monocyte responses than those who were not revaccinated. Monocyte concentration in subjects re-vaccinated within 1 month of study start appeared maximal at 48 h post-injection. Conclusion: This assay represents a novel approach that allows for quantification of dermal monocyte/macrophage influx. This clinical methodology has potential utility in the pharmacodynamic evaluation of therapies targeting inflammatory disorders, which involve monocyte tissue recruitment, like the delayed-type hypersensitivity response.

Publisher

Future Medicine Ltd

Subject

Biochemistry, medical,Clinical Biochemistry,Drug Discovery

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3